首页> 外文期刊>Annals of Clinical Microbiology and Antimicrobials >Detection of bacterial DNA from central venous catheter removed from patients by next generation sequencing: a preliminary clinical study
【24h】

Detection of bacterial DNA from central venous catheter removed from patients by next generation sequencing: a preliminary clinical study

机译:下一代测序技术检测患者中心静脉导管中细菌DNA的初步临床研究

获取原文
           

摘要

Catheter-related infection (CRI) is one of the serious challenges in clinical practice. This preliminary clinical study aimed to examine whether next-generation sequencing (NGS) targeting 16S rDNA, which was PCR-amplified directly from the tip of a central venous catheter (CVC), can be used to identify causative pathogens in CRI, compared to the culture method. Hospitalized patients, from whom a CVC had just been removed, were prospectively enrolled and divided into the CRI-suspected and routine removal groups. DNA was extracted from the sonication fluid of CVC specimens derived from patients. For analysis of bacterial composition by NGS, the V3–V4 fragments of bacterial 16S rDNA were PCR-amplified, followed by index PCR and paired-end sequencing on an Illumina MiSeq device. Conventional culture methods were also performed in the CRI-suspected group. Of CVCs collected from the 156 enrolled patients (114 men; mean age 65.6?years), a total of 14 specimens [nine out of 31 patients suspected with CRI and five out of 125 patients without infection symptoms (routine removal group)] were PCR-positive. In five patients with definite CRI, Staphylococcus was the most frequently detected genus by NGS (4/5 specimens), although no pathogens were detected by NGS in the one remaining specimen. The genera identified by NGS were consistent with those from conventional culture tests. There was high agreement between NGS and the culture method in the CRI-suspected group, with sensitivity and specificity values of 80.0% and 76.9%, respectively; meanwhile, the false-positive rate of NGS was as low as 4.0% in the routine removal group. Moreover, several genera, besides the genus identified by culture test, were detected in each patient with definite CRI and surgical site infection (SSI). Additionally, in one patient with SSI, Enterococcaceae were detected not only by NGS but also by abdominal abscess drainage culture. NGS targeting 16S rDNA was able to analyze the bacterial composition of CVC specimens and detect causative pathogens in patients with CRI and was therefore suggested as a promising diagnostic tool for CRI.
机译:导管相关感染(CRI)是临床实践中的严重挑战之一。这项初步的临床研究旨在检查针对16S rDNA的下一代测序(NGS),该测序直接从中央静脉导管(CVC)尖端进行PCR扩增,与CRI相比,是否可用于鉴定CRI中的致病菌培养方法。前瞻性地招募了刚刚从中取出CVC的住院患者,并将其分为CRI怀疑组和常规去除组。从患者的CVC标本的超声处理液中提取DNA。为了通过NGS分析细菌组成,对16S rDNA的V3-V4片段进行PCR扩增,然后在Illumina MiSeq设备上进行索引PCR和双末端测序。在CRI怀疑组中也进行了常规培养方法。在从156名入组患者(114名男性;平均年龄65.6岁)中收集的CVC中,共进行了14份标本[31名疑似CRI的患者中有9名,而无感染症状的125名患者(常规清除组)中有5名] -正。在5例CRI明确的患者中,葡萄球菌是NGS检出率最高的属(4/5个标本),尽管在剩下的1个标本中NGS没有检出病原体。 NGS鉴定的属与常规培养试验的属一致。在CRI怀疑组中,NGS与培养方法之间的一致性很高,敏感性和特异性分别为80.0%和76.9%。同时,常规去除组的NGS假阳性率低至4.0%。此外,除了通过培养测试确定的属外,在每位具有明确CRI和手术部位感染(SSI)的患者中还检测到了多个属。此外,在一例SSI患者中,不仅通过NGS还通过腹腔脓肿引流培养检测到肠球菌。靶向16S rDNA的NGS能够分析CVC标本的细菌成分并检测CRI患者的病原体,因此被建议作为CRI的有前途的诊断工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号